Swiss National Bank Sells 7,600 Shares of Premier, Inc. (NASDAQ:PINC)

Swiss National Bank trimmed its position in Premier, Inc. (NASDAQ:PINC) by 3.7% in the 4th quarter, HoldingsChannel reports. The fund owned 197,112 shares of the company’s stock after selling 7,600 shares during the quarter. Swiss National Bank’s holdings in Premier were worth $4,179,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors have also added to or reduced their stakes in the company. Brooklyn Investment Group increased its stake in shares of Premier by 61,750.0% in the fourth quarter. Brooklyn Investment Group now owns 1,237 shares of the company’s stock worth $26,000 after purchasing an additional 1,235 shares in the last quarter. SRS Capital Advisors Inc. boosted its holdings in Premier by 157.8% in the 4th quarter. SRS Capital Advisors Inc. now owns 1,284 shares of the company’s stock worth $27,000 after buying an additional 786 shares during the period. Keystone Financial Group Inc. purchased a new stake in Premier in the 4th quarter worth $37,000. Wilmington Savings Fund Society FSB bought a new stake in Premier during the third quarter valued at about $39,000. Finally, Smartleaf Asset Management LLC raised its holdings in Premier by 297.9% during the fourth quarter. Smartleaf Asset Management LLC now owns 1,906 shares of the company’s stock valued at $40,000 after acquiring an additional 1,427 shares during the period. Hedge funds and other institutional investors own 74.41% of the company’s stock.

Wall Street Analysts Forecast Growth

Several analysts recently issued reports on the company. Robert W. Baird cut their target price on Premier from $20.00 to $19.00 and set a “neutral” rating for the company in a research report on Wednesday, February 5th. Canaccord Genuity Group cut their price objective on shares of Premier from $21.00 to $19.00 and set a “hold” rating for the company in a report on Wednesday, February 5th. Finally, Piper Sandler reduced their price objective on shares of Premier from $21.00 to $19.00 and set a “neutral” rating on the stock in a research report on Wednesday, February 5th. Eight investment analysts have rated the stock with a hold rating, Based on data from MarketBeat.com, Premier currently has a consensus rating of “Hold” and a consensus price target of $20.17.

Insider Buying and Selling

In related news, Director Helen M. Boudreau sold 2,500 shares of Premier stock in a transaction dated Monday, January 6th. The stock was sold at an average price of $21.42, for a total value of $53,550.00. Following the completion of the transaction, the director now owns 20,668 shares in the company, valued at approximately $442,708.56. This trade represents a 10.79 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. 0.96% of the stock is currently owned by company insiders.

Premier Trading Down 0.7 %

Shares of Premier stock opened at $18.95 on Wednesday. The firm has a market cap of $1.73 billion, a PE ratio of -189.48 and a beta of 0.39. The stock has a 50 day moving average of $19.51 and a 200 day moving average of $20.49. Premier, Inc. has a 12 month low of $17.23 and a 12 month high of $23.56.

Premier Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Saturday, March 15th. Investors of record on Saturday, March 1st were issued a $0.21 dividend. This represents a $0.84 dividend on an annualized basis and a dividend yield of 4.43%. The ex-dividend date was Friday, February 28th. Premier’s dividend payout ratio (DPR) is presently -840.00%.

Premier Company Profile

Premier, Inc, together with its subsidiaries, operates as a healthcare improvement company in the United States. It operates in two segments, Supply Chain Services and Performance Services. The Supply Chain Services segment offers its members with an access to a range of products and services, including medical and surgical products, pharmaceuticals, laboratory supplies, capital equipment, information technology, facilities and construction, and food and nutritional products, as well as purchased services, such as clinical engineering and workforce solutions.